<?xml version="1.0" encoding="UTF-8"?>
<records xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://www.doaj.org/schemas/doajArticles.xsd">


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2023-12-11</publicationDate>
              <volume>8</volume>
              <issue>3</issue>
              <startPage>117</startPage>
              <endPage>121</endPage>
              <doi>10.26663/cts.2023.0021</doi>
              <publisherRecordId>206</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Does lung cancer histology affect the efficacy of talc pleurodesis throughpleural catheter?</title>
                <authors>
                              <author>
                                <name>Melike  Badoglu</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Hüsnü  Baykal</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Chest Diseases, Ankara Atatürk Sanatoryum Training and Research Hospital, University of Health Sciences, Ankara, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background:&lt;/b&gt; Up to 50% of lung cancer patients develop pleural effusion during the course of the disease.
Dyspnea is the primary indication for intervention. After drainage, chemical pleurodesis may be applied.
Talc is the most effective sclerosing agent, and sometimes the procedure may not be successful. Adults,
histologically confirmed lung cancer patients with pleural effusion who had talc pleurodesis through pleural
catheter between 2014 and 2019 were included. The aim was to clarify whether lung cancer histological
type and talc pleurodesis efficacy were correlated or not.&lt;p&gt;
&lt;b&gt;Materials and Methods:&lt;/b&gt; A total 222 patients were enrolled retrospectively. Through the study; age, sex,
cancer histological type, pleural/pleural effusion FDG uptake in PET/CT, pleural effusion’s location,
amount, biochemical property, and pleurodesis efficacy were recorded.&lt;p&gt;
&lt;b&gt;Results:&lt;/b&gt; Mean age was 65.52 years, 22.9% of them were women, and 73.3% were men. Lung cancer
histological types were; small cell lung cancer (13.1%), adenocarcinoma (72.1%), squamous cell carcinoma
(9.5%), and not specified non-small cell lung cancer (5.4%). In 22.1% of the patients, pleurodesis was
efficient, in 50% partially efficient, and in 27.9% inefficient. The only independent factor affecting
pleurodesis efficacy was found as cancer histological type (p &lt; 0.05). Pleurodesis efficacy was found
higher in the squamous cell carcinoma group (p &lt; 0.05).&lt;p&gt;
&lt;b&gt;Conclusions: &lt;/b&gt;As far as we know, this is the first study on correlation between efficacy of talc pleurodesis
through the pleural catheter and the lung cancer histological types. Pleurodesis was significantly more
efficient in patients with squamous cell carcinoma, possibly due to its immunohistochemical behavior.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=206</fullTextUrl>
              <keywords><keyword>lung cancer</keyword><keyword>malignant pleural effusion</keyword><keyword>pleurodesis efficacy</keyword><keyword>talc pleurodesis</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2023-12-11</publicationDate>
              <volume>8</volume>
              <issue>3</issue>
              <startPage>122</startPage>
              <endPage>127</endPage>
              <doi>10.26663/cts.2023.0022</doi>
              <publisherRecordId>207</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Did covid-19 anxiety cause a delay in the patients’ decision to be operated on for lung malignancy?</title>
                <authors>
                              <author>
                                <name>Seda Kahraman Aydın</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Tiffany Melissa Ergin Onar</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Tevfik Ilker Akcam</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Ufuk  Cagirici</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Ali  Ozdil</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Ege University School of Medicine, Izmir, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background:&lt;/b&gt; With the COVID-19 pandemic, &quot;corona anxiety and phobia&quot; negatively affect people in
various fields which can lead patients to delay even their lung cancer operations. It was investigated
whether the reason was COVID-19 phobia in patients who wanted to postpone lung surgery, and it was
aimed to evaluate the COVID-19 anxiety scores in these patients.&lt;p&gt;
&lt;b&gt;Materials and Methods: &lt;/b&gt;Between April 2020 and January 2022, the data of patients who were
recommended to be operated on due to lung malignancy, but who reported that they wanted to postpone
the surgery were analyzed retrospectively. The patients were contacted by phone and questioned
whether the reasons for the postponement were the COVID-19 pandemic. The patients were evaluated
in the context of the “Coronavirus Anxiety Scale (CAS)” and their anxiety scores and reasons for delay
were analyzed with CAS scores.&lt;p&gt;
&lt;b&gt;Results:&lt;/b&gt; Of the 122 patients who were recommended to be operated on due to lung malignancy, 90
were operated on, while 32 patients (26.2%) postponed the operation. The mean surgery delay time
was 11.59 ± 7.13 months, it was detected that the mean anxiety score was 2.47 ± 2.46 (0-9) points.
The average anxiety score of those who answered “no” to the questionnaire was 0.79 points, those
who answered “partially” had 2.69 points, and those who answered “yes” were 6.60 points. The CAS
score was significantly higher in patients who reported that they postponed their surgeries mainly due
to COVID-19 (p &lt; 0.001).&lt;p&gt;
&lt;b&gt;Conclusions:&lt;/b&gt; Higher levels of coronavirus anxiety were detected in patients who reported that they
postponed lung surgery due to COVID-19.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=207</fullTextUrl>
              <keywords><keyword>coronaphobia</keyword><keyword>coronavirus anxiety</keyword><keyword>delay</keyword><keyword>lung cancer</keyword><keyword>surgical treatment</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2023-12-11</publicationDate>
              <volume>8</volume>
              <issue>3</issue>
              <startPage>128</startPage>
              <endPage>135</endPage>
              <doi>10.26663/cts.2023.0023</doi>
              <publisherRecordId>208</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Chest wall reconstructions with synthetic prosthetic materials</title>
                <authors>
                              <author>
                                <name>Seray  Hazer</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Necati  Solak</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Leyla Nesrin Üstün</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Pınar  Bıçakçıoğlu</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Göktürk  Fındık</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Selim Şakir Erkmen Gülhan</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Ankara Atatürk Sanatoryum Training and Research Hospital, Ankara, Turkey</affiliationName><affiliationName affiliationId="2">Department of Thoracic Surgery, Sincan Training and Research Hospital, Ankara, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background:&lt;/b&gt; Chest wall tumors can be malignant and benign and present as primary or metastatic
lesions. For the definitive treatment of malignant thoracic wall tumors, the surgical margin should be
established at a distance of at least 4 cm from the tumor. A 1-2 cm distance from the tumor is often
sufficient in benign or low-grade malignancies. Repairing the deformity with prosthetic materials in 3
or more rib resections (&gt;30 cm) is recommended. In resections containing four or more ribs, the mesh
should be supported with metallic rib bars screwed to the periphery of the defect.&lt;p&gt;
&lt;b&gt;Materials and Methods: &lt;/b&gt;Thoracic wall resection was performed on 285 patients between 2008 and
2019 in the Department of Thoracic Surgery of Ankara Atatürk Sanatoryum Training and Research
Hospital. Repair with prosthetic graft was performed in 70 cases, and thoracic wall resection was
performed in 215 patients without using mesh. The results of 50 patients who underwent thoracic wall
reconstruction with a prosthetic graft were evaluated retrospectively.&lt;p&gt;
&lt;b&gt;Results:&lt;/b&gt; The female/male ratio in those using mesh is 0.47; the mean age is 52.5 (14-76 years); the
tumor size (mean long diameter) is 11 cm (4-18 cm); the number of removed ribs is 2.5 (1-5 pieces)
is Sternal resection was performed in 2 patients, sternum resection in 1 patient, left clavicle partial
resection, right clavicle partial resection, and first and second ribs of the left side resection. Partial
excision of the clavicle and first rib was performed in 1 patient. Polypropylene mesh in 28, PTFE mesh
in 20, and polyglactin mesh in 2 patients were used. The mean postoperative hospital stay was 10.6
days (2-58 days), and the mean follow-up period was 16.6 months (0-96 months, median 7 months).
Complications developed in 10 patients (20.0%). Three patients underwent revision surgery; one was
operated on for empyema at four months, and the patch was removed. The others were performed at
the 16th and 30th months due to recurrence. Mortality developed in 4 patients in long-term follow-ups.&lt;p&gt;
&lt;b&gt;Conclusions:&lt;/b&gt; Polypropylene mesh can cause wrinkles and folds as it shows less stretch when suturing
than Polytetrafluoroethylene (PTFE). In addition to the difficulties of providing a smooth surface, it also
causes the passage of fluid and air in the pleural space from the pores to the subcutaneous space. PTFE
patches are frequently used, non-permeable, flexible, high tissue compatibility, durable and robust, but
poor body wall integration has been reported. Polypropylene and PTFE mesh comparison results are
similar to the literature. Suppose a significant defect (&gt;30 cm2) exists in patients who have undergone
thoracic wall resection; reconstruction should be performed to stabilize the thoracic wall, prevent lung
hernia, paradoxical breathing, mediastinal structures, and intrathoracic dislocation of the scapula, and
provide aesthetically appropriate rib cage contours.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=208</fullTextUrl>
              <keywords><keyword>chest wall</keyword><keyword>reconstruction</keyword><keyword>polyprolen mesh</keyword><keyword>PTFE</keyword><keyword>thoracic surgery</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2023-12-11</publicationDate>
              <volume>8</volume>
              <issue>3</issue>
              <startPage>136</startPage>
              <endPage>142</endPage>
              <doi>10.26663/cts.2023.0024</doi>
              <publisherRecordId>209</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Postpneumonectomy bronchopleural fistula: cohort of patients in a pevurian national hospital</title>
                <authors>
                              <author>
                                <name>Karin  Gonzales-Peña</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>W Samir Cubas</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Pamela  Villanueva-Zúñiga</name>
                                <affiliationId>3</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Service of Thorax and Cardiovascular Surgery, Hipolito Unánue National Hospital, Lima, Peru</affiliationName><affiliationName affiliationId="2">Department of Thoracic and Cardiovascular Surgery, Edgardo Rebagliati Martins National Hospital, Lima, Peru</affiliationName><affiliationName affiliationId="3">Postgraduate Area, School of Medicine, Universidad San Martín de Porres, Lima, Peru</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background: &lt;/b&gt;Bronchopleural fistula (BPF) is a complication with a great impact on morbidity,
mortality and survival in postoperative pneumonectomy patients. Our study aimed to determine
the associated clinical-surgical characteristics of the BPF in a Peruvian cohort of patients with BPF
following pneumonectomy.&lt;p&gt;
&lt;b&gt;Materials and Methods:&lt;/b&gt; Cross-sectional, and retrospective study during January 2015-June 2020 in a
Peruvian National Hospital. Medical records and operative reports were reviewed, and all patients over
age (&gt;18 years) and with all-cause pneumonectomy were considered. The variables were grouped into
pneumonectomies with and without BPF, and the characteristics were grouped as a baseline, clinicalsurgical
and postoperative.&lt;p&gt;
&lt;b&gt;Results: &lt;/b&gt;Among fifty-seven patients who underwent pneumonectomy, 28% presented BPF. The mean
age was 38.3 ± 15 years, and 62.5% were male. The main pathologies associated with BPF were posttuberculosis
fibrocavitary sequelae (62.5%), pulmonary hydatidosis (18.8%), and post-surgical cavitary
sequelae (12.5%). 81.3% were left BPF (p = 0.342) and 100% were related to postoperative empyema (p
&amp;lt; 0.05). The mortality associated with BPF was 6.25%, and in the non-BPF group it was 4.87% (p =
0.098). Characteristics that were statistically associated with the presence of bronchopleural fistula were
low predicted forced expiratory volume (FEV1) (56.3% vs. 31.7%; p = 0.046), preoperative empyema
(37.5% vs. 2.4%; p = 0.001), postoperative empyema (100% vs. 9.8%; p = 0.000) and operative time
(450.69 min vs. 367.73 min; p = 0.032).&lt;p&gt;
&lt;b&gt;Conclusions: &lt;/b&gt;There are a series of factors associated with the presence of patients with BPF following
pneumonectomy, many of them mainly related to operative and postoperative events, which is an
important predictor of associated complications in our Peruvian population.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=209</fullTextUrl>
              <keywords><keyword>bronchopleural fistula; pneumonectomy; empyema; tuberculosis; complication</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2023-12-11</publicationDate>
              <volume>8</volume>
              <issue>3</issue>
              <startPage>143</startPage>
              <endPage>147</endPage>
              <doi>10.26663/cts.2023.0025</doi>
              <publisherRecordId>210</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Pathological diagnoses and adenosine deaminase levels in patients undergoing pericardial window operation for large pericardial effusions</title>
                <authors>
                              <author>
                                <name>Ayfer  Utkusavas</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Murat  Akkus</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Ilker  Kolbas</name>
                                <affiliationId>3</affiliationId>
                              </author>
                              <author>
                                <name>Hande  Ikitimur</name>
                                <affiliationId>4</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Pulmonology, Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey</affiliationName><affiliationName affiliationId="2">Department of Thoracic Surgery, Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey</affiliationName><affiliationName affiliationId="3">Department of Thoracic Surgery, Istanbul Aydin University Medical Faculty, Istanbul, Turkey</affiliationName><affiliationName affiliationId="4">Department of Pulmonology, Istanbul Aydin University Medical Faculty, Istanbul, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background:&lt;/b&gt; It might be challenging to determine the etiology of pericardial effusions as studies
have usually focused on pericardial effusions in patients suspected to have specific underlying clinical
conditions. We aimed to evaluate adenosine deaminase (ADA) levels in pericardial fluid samples
of patients with large pericardial effusions in whom pericardial window surgeries with biopsy and
pathological examinations were carried out.&lt;p&gt;
&lt;b&gt;Materials and Methods:&lt;/b&gt; Pericardial fluid ADA levels of 149 consecutive patients having large pericardial
effusions were evaluated. Pericardial effusion was detected by transthoracic echocardiography, ADA
levels were measured from the fluid taken during pericardial windowing procedure, and pathological
examination of the tissue samples were performed.&lt;p&gt;
&lt;b&gt;Results:&lt;/b&gt; The median age of selected patients participating in the study was 58.43 ± 14.47 years. All the
pericardial fluid samples were found to be exudative and 116 (77.9 %) of the cases had also concomitant
pleural effusions. The median ADA level of the cases was calculated to be 19.57 U/L (9.47-38.70), well
below the cut-off value (40 U/L). The mean ADA levels value was 9.21 U/L (7.70-9.91) in the nonspecific
inflammations group and 38.35 U/L (23.92-48.67) in the lung malignancy group (p &lt; 0.001). In the
subgroup analysis of lung cancers, ADA levels in pericardial effusions of patients with adenocarcinoma
were found to be statistically significantly higher than patients with squamous cell cancer. (p = 0.007).&lt;p&gt;
&lt;b&gt;Conclusion:&lt;/b&gt; ADA levels in pericardial effusion were found to be significantly higher in lung cancer,
especially in cases of lung adenocarcinoma. High levels of ADA may be used as a significative
biochemical marker in the diagnosis of lung cancer.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=210</fullTextUrl>
              <keywords><keyword>pericardial effusion</keyword><keyword>adenosine deaminase</keyword><keyword>cancer</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2023-12-11</publicationDate>
              <volume>8</volume>
              <issue>3</issue>
              <startPage>148</startPage>
              <endPage>150</endPage>
              <doi>10.26663/cts.2023.0026</doi>
              <publisherRecordId>211</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Video-assisted thoracoscopic surgery lobectomy with guillotine stapler technique for the second primary adenocarcinoma of the lung after immunotherapy</title>
                <authors>
                              <author>
                                <name>Dilara  Gürsoy</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Özgür  Samancılar</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Kutsal  Turhan</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Faculty of Medicine, Ege University, Izmir, Turkey</affiliationName><affiliationName affiliationId="2">Department of Thoracic Surgery, Medicana Hospital, Izmir, Turkey</affiliationName></affiliationsList><abstract language="eng">Immunotherapy is gaining increasing attention as a neoadjuvant therapy for resectable non-small cell
lung cancer (NSCLC). We report a case with second primary lung adenocarcinoma that was applied
via video-assisted thoracoscopic surgery (VATS) lobectomy with guillotine stapler technique after
treatment with immunotherapy in combination with chemotherapy. Although surgery is challenging
after immunotherapy, this particular case showed that the VATS approach may be safe and feasible in
experienced hands.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=211</fullTextUrl>
              <keywords><keyword>non-small cell lung cancer</keyword><keyword>neoadjuvant therapy</keyword><keyword>immunotherapy</keyword><keyword>video-assisted thoracoscopic surgery (VATS)</keyword><keyword>nivolumab</keyword><keyword>lung resection</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2023-12-11</publicationDate>
              <volume>8</volume>
              <issue>3</issue>
              <startPage>151</startPage>
              <endPage>154</endPage>
              <doi>10.26663/cts.2023.0027</doi>
              <publisherRecordId>212</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Pulmonary carcinoid tumor of endobronchial presentation: a case report</title>
                <authors>
                              <author>
                                <name>Mayra  Valderrama-Saldaña</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>W Samir Cubas</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Helen  Reina</name>
                                <affiliationId>3</affiliationId>
                              </author>
                              <author>
                                <name>José  Somocursio</name>
                                <affiliationId>3</affiliationId>
                              </author>
                              <author>
                                <name>Max  Small</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Service of Pneumology, Edgardo Rebagliati Martins National Hospital, Lima, Peru</affiliationName><affiliationName affiliationId="2">Department of Thoracic and Cardiovascular Surgery, Edgardo Rebagliati Martins National Hospital, Lima, Peru</affiliationName><affiliationName affiliationId="3">Service of Pathological Anatomy, Edgardo Rebagliati Martins National Hospital, Lima, Peru</affiliationName></affiliationsList><abstract language="eng">Lung carcinoid tumors account for 1-2% of malignant lung neoplasms. Early diagnosis is crucial, and
surgery at an early stage may improve the clinical picture and may even be a curative option. We present
a 78-year-old woman with a history of poorly controlled arterial hypertension, anxious syndrome, irritable
bowel syndrome, and paroxysmal palpitations for the last two years. Radiologic imaging showed a left
hilar nodular lesion causing endobronchial obstruction in the left lower lobe. Anatomopathology revealed
a low-grade pulmonary neuroendocrine tumor, and pulmonary resection with nodal staging was promptly
considered. The diagnosis of pulmonary carcinoid tumor is challenging; therefore, it is necessary to
maintain suspicion in patients with non-specific and/or persistent respiratory symptoms, and complete
resection and prolonged close follow-up should be considered despite a satisfactory postoperative course.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=212</fullTextUrl>
              <keywords><keyword>carcinoid tumor</keyword><keyword>neuroendocrine tumor</keyword><keyword>lung tumor</keyword><keyword>carcinoid syndrome</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2023-12-11</publicationDate>
              <volume>8</volume>
              <issue>3</issue>
              <startPage>155</startPage>
              <endPage>159</endPage>
              <doi>10.26663/cts.2023.0028</doi>
              <publisherRecordId>213</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">First awake uniportal video assisted thoracoscopic lobectomy in turkey</title>
                <authors>
                              <author>
                                <name>Volkan  Karaçam</name>
                                <affiliationId></affiliationId>
                              </author>
                              <author>
                                <name>Gönül  Sagıroglu</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Emrah  Karcı</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Fatma  Mutlu</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Ilkay  Kaya</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey</affiliationName><affiliationName affiliationId="2">Department of Anestesia and Reanimation, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey</affiliationName></affiliationsList><abstract language="eng">As in all surgical branches, the importance of minimally invasive surgery in thoracic surgery has been
increasing in recent years. Especially in the last decade, the preference of thoracic surgeons is mostly in
favor of VATS. As a result of today's developing technology and experience, minimally invasive surgery
is not limited to surgical technique only, and less invasive non-intubated methods have been started to be
used in anesthesia applications. While non-intubated (awake) VATS is usually applied for reasons such as
pleural effusion, empyema, hemothorax, pneumothorax, it is now preferred for anatomical resection of the
lung. We also prefer the awake VATS method in suitable patients in our clinic. In this study, we aimed to
talk about our case in which we performed left lower lobectomy and mediastinal lymph node dissection
with awake uVATS (uniportal VATS) method in our clinic.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=213</fullTextUrl>
              <keywords><keyword>awake anesthesia</keyword><keyword>uniportal VATS</keyword><keyword>lobectomy</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2023-12-11</publicationDate>
              <volume>8</volume>
              <issue>3</issue>
              <startPage>160</startPage>
              <endPage>162</endPage>
              <doi>10.26663/cts.2023.0029</doi>
              <publisherRecordId>214</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Tuberous sclerosis and chylothorax</title>
                <authors>
                              <author>
                                <name>Burcu Oksuz Gungor</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Sami  Karapolat</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Omer  Topaloglu</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Atila  Turkyilmaz</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey</affiliationName></affiliationsList><abstract language="eng">A 48-year-old female with tuberous sclerosis admitted with shortness of breath. The chest radiography
revealed a left sided hydropneumothorax. A tube thoracostomy was and 2000 cc of chylous fluid was
drained. As the daily drainage was not reduced, ligation of the thoracic duct was performed. The patient
was discharged uneventfully. In cases of tuberous sclerosis presenting with chylothorax, a successful
treatment can be applied with early thoracic duct mass ligation.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=214</fullTextUrl>
              <keywords><keyword>tuberous sclerosis</keyword><keyword>chylothorax</keyword><keyword>surgery</keyword>
                  </keywords>
            </record></records>